CE-224,535 ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	7

46. Malignant rheumatoid arthritis

Clinical trials : 4,325 / Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224

diseases per page:

Showing 1 to 7 of 7 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00838058 (ClinicalTrials.gov)	January 2009	2/2/2009	A Study in Normal Healthy People, Testing Different Versions of a Pill That Will be Used to Treat Rh ...	An Open-Label Two-Part Randomized, Crossover Study Of The Pharmacokinetics Of CE-224,535Administered ...	Rheumatoid Arthritis;Healthy Volunteers	Drug: CE-224,535;Drug: CE 224,535	Pfizer	NULL	Completed	18 Years	55 Years	Both	11	Phase 1	United States
2	NCT00782600 (ClinicalTrials.gov)	July 2008	27/10/2008	Study of Controlled Release Formulations of CE-224,535Against the Immediate Release Formulation in N ...	A Phase 1, Randomized, 4-Period, 4-Sequence Cross-Over Study Of The Pharmacokinetics Of 3 Durations ...	Rheumatoid Arthritis	Drug: suspension IR;Drug: CR 1;Drug: CR 2;Drug: CR 3	Pfizer	NULL	Completed	18 Years	55 Years	Both	16	Phase 1	United States
3	EUCTR2008-000327-25-PL (EUCTR)	24/06/2008	20/05/2008	A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,PARALLEL-GROUP STUDY OF CE-224,535, AN ANTA ...	A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,PARALLEL-GROUP STUDY OF CE-224,535, AN ANTA ...	Rheumatoid Arthritis MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Name: CE-224,535	Pfizer Inc. 235 East 42nd Street NY10017	NULL	Not Recruiting			Female: yes Male: yes	78	Phase 2	Czech Republic;Spain;Poland
4	EUCTR2008-000327-25-CZ (EUCTR)	27/05/2008	02/04/2008	A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,PARALLEL-GROUP STUDY OF CE-224,535, AN ANTA ...	A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,PARALLEL-GROUP STUDY OF CE-224,535, AN ANTA ...	Rheumatoid Arthritis MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid ar ...	Product Name: CE-224,535	Pfizer Inc. 235 East 42nd Street NY10017	NULL	Not Recruiting			Female: yes Male: yes	78	Phase 2	Czech Republic;Spain;Poland
5	EUCTR2008-000327-25-ES (EUCTR)	19/05/2008	18/03/2008	ESTUDIO DE FASE 2A ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO Y DE GRUPOS PARALELOS DE CE-224 ...	ESTUDIO DE FASE 2A ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO Y DE GRUPOS PARALELOS DE CE-224 ...	Artritis Reumatoide MedDRA version: 9.1;Level: LLT;Classification code 10039073;Term: Rheumatoid art ...	Product Name: CE-224,535	PFIZER S.A.	NULL	Not Recruiting			Female: yes Male: yes	78	Phase 2	Czech Republic;Poland;Spain
6	NCT00628095 (ClinicalTrials.gov)	March 2008	25/2/2008	Study of CE-224,535A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Total ...	A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of CE-224,535, An Ant ...	Arthritis, Rheumatoid	Drug: CE-224,535;Drug: Placebo	Pfizer	NULL	Completed	18 Years	N/A	Both	100	Phase 2/Phase 3	United States;Chile;Czech Republic;Korea, Republic of;Mexico;Poland;Spain
7	NCT00446784 (ClinicalTrials.gov)	April 2007	9/3/2007	Study Of The Safety Of CE 224,545 And Methotrexate In Patients With Rheumatoid Arthritis	A Phase 1, Double Blind Study Of The Safety And Pharmacokinetics Of Multiple Doses Of CE 224,535 In ...	Arthritis, Rheumatoid	Drug: CE-224,535;Drug: Methotrexate	Pfizer	NULL	Completed	18 Years	N/A	Both	20	Phase 1	United States

First Previous1Next Last